Scientists have identified a previously unknown trigger involved in Alzheimer’s disease and developed an experimental drug that may help stop it. The treatment targets a harmful process occurring inside brain cells that contributes to nerve cell damage and disease progression. In laboratory studies, mice treated with the compound showed slower loss of neurons, fewer Alzheimer’s-related brain changes, and signs of healthier aging overall. While the research is still in its early stages and human trials are needed, the findings offer promising new insights into how Alzheimer’s develops and suggest a potential new strategy for protecting the brain from age-related cognitive decline.
Read more at ScienceDaily